Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edgewise Therapeutics (EWTX) Cash from Investing Activities (2020 - 2026)

Edgewise Therapeutics has reported Cash from Investing Activities over the past 7 years, most recently at $2.4 million for Q1 2026.

  • Quarterly results put Cash from Investing Activities at $2.4 million for Q1 2026, down 94.46% from a year ago — trailing twelve months through Mar 2026 was -$74.3 million (down 158.22% YoY), and the annual figure for FY2025 was -$32.8 million, up 82.24%.
  • Cash from Investing Activities reached $2.4 million in Q1 2026 per EWTX's latest filing, down from $49.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $49.8 million in Q4 2025 and bottomed at -$268.3 million in Q1 2024.
  • Median Cash from Investing Activities over the past 5 years was $23.4 million (2023), compared with a mean of -$10.7 million.
  • The largest annual shift saw Cash from Investing Activities soared 7582.61% in 2023 before it crashed 647.1% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$75.6 million in 2022, then skyrocketed by 135.69% to $27.0 million in 2023, then decreased by 22.46% to $20.9 million in 2024, then skyrocketed by 137.85% to $49.8 million in 2025, then crashed by 95.11% to $2.4 million in 2026.
  • Business Quant data shows Cash from Investing Activities for EWTX at $2.4 million in Q1 2026, $49.8 million in Q4 2025, and $35.7 million in Q3 2025.